Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 10/20 | 0.40 |
| ▸ | LPL | P06858 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 3/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10034350 | 1.00 | PDK2 (0.40) | PDK2LPLLIPGESR1ESR2 | |
| SCHEMBL10034420 | 1.00 | PDK2 (0.40) | PDK2LPLLIPGESR1ESR2 | |
| SCHEMBL16366430 | 1.00 | PDK2 (0.40) | PDK2LPLLIPGESR1ESR2 | |
| SCHEMBL10034348 | 1.00 | PDK2 (0.40) | PDK2LPLLIPGESR1ESR2 | |
| SCHEMBL17153730 | 1.00 | PDK2 (0.40) | PDK2LPLLIPGESR1ESR2 | |
| SCHEMBL17153662 | 1.00 | PDK2 (0.40) | PDK2LPLLIPGESR1ESR2 | |
| SCHEMBL10034406 | 1.00 | PDK2 (0.40) | PDK2LPLLIPGESR1ESR2 | |
| SCHEMBL16366541 | 1.00 | PDK2 (0.40) | PDK2LPLLIPGESR1ESR2 | |
| SCHEMBL16366135 | 1.00 | PDK2 (0.40) | PDK2LPLLIPGESR1ESR2 | |
| SCHEMBL21968964 | 0.99 | PDK2 (0.39) | PDK2LPLLIPGESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12048239-B2 | Composition for organic optoelectronic device, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2024-07-23 | — | — | US | disclosed |
| US-12048239-B2 | Composition for organic optoelectronic device, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2024-07-23 | — | — | US | disclosed |
| US-20220149295-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2022-05-12 | — | — | US | disclosed |
| US-20210328144-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220149295-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OCIAD2, OR10J3, OCIAD1 | PDK2 3057/4885LPL 2652/4885LIPG 1365/4885 |
| US-20210328144-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OR10J3, OCIAD2, OCIAD1 | PDK2 3157/4885LPL 3099/4885LIPG 1564/4885 |
| US-12048239-B2 | Composition for organic optoelectronic device, organic optoelectronic device and display device | OR10J3, OCIAD2, OCIAD1 | PDK2 3157/4885LPL 3099/4885LIPG 1564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.